Plus Disease

Bradley V. Davitt, David K. Wallace

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

Our understanding of plus disease as an important sign for severe retinopathy of prematurity (ROP) has gradually been refined over the past 30 years. As a result of the Early Treatment for ROP (ETROP) randomized trial, the presence of plus disease is now the primary indication for laser treatment. Since the Cryotherapy for ROP trial first introduced a standard photograph as the minimum abnormality necessary for diagnosing plus disease, an intermediate level of vascular dilatation and tortuosity (pre-plus disease) has been defined. However, the recognition of plus disease remains problematic, primarily because of its subjective nature. As our understanding of the pathologic basis for plus disease in ROP grows, objective methods of recognizing and measuring retinal vascular abnormalities are also being designed. Semiautomated methods are being developed to quantify the vascular morphologic changes seen in plus disease and show promise for augmenting clinical judgment in the recognition and timely treatment of ROP.

Original languageEnglish (US)
Pages (from-to)663-670
Number of pages8
JournalSurvey of Ophthalmology
Volume54
Issue number6
DOIs
StatePublished - Nov 1 2009
Externally publishedYes

Fingerprint

Retinopathy of Prematurity
Blood Vessels
Retinal Vessels
Cryotherapy
Dilatation
Lasers
Therapeutics

Keywords

  • ETROP
  • ICROP
  • plus disease
  • pre-plus disease
  • prematurity
  • retinopathy
  • ROPtool
  • threshold

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Plus Disease. / Davitt, Bradley V.; Wallace, David K.

In: Survey of Ophthalmology, Vol. 54, No. 6, 01.11.2009, p. 663-670.

Research output: Contribution to journalReview article

Davitt, Bradley V. ; Wallace, David K. / Plus Disease. In: Survey of Ophthalmology. 2009 ; Vol. 54, No. 6. pp. 663-670.
@article{1e012726d3f649f9a6118e1f54638930,
title = "Plus Disease",
abstract = "Our understanding of plus disease as an important sign for severe retinopathy of prematurity (ROP) has gradually been refined over the past 30 years. As a result of the Early Treatment for ROP (ETROP) randomized trial, the presence of plus disease is now the primary indication for laser treatment. Since the Cryotherapy for ROP trial first introduced a standard photograph as the minimum abnormality necessary for diagnosing plus disease, an intermediate level of vascular dilatation and tortuosity (pre-plus disease) has been defined. However, the recognition of plus disease remains problematic, primarily because of its subjective nature. As our understanding of the pathologic basis for plus disease in ROP grows, objective methods of recognizing and measuring retinal vascular abnormalities are also being designed. Semiautomated methods are being developed to quantify the vascular morphologic changes seen in plus disease and show promise for augmenting clinical judgment in the recognition and timely treatment of ROP.",
keywords = "ETROP, ICROP, plus disease, pre-plus disease, prematurity, retinopathy, ROPtool, threshold",
author = "Davitt, {Bradley V.} and Wallace, {David K.}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.survophthal.2009.02.021",
language = "English (US)",
volume = "54",
pages = "663--670",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Plus Disease

AU - Davitt, Bradley V.

AU - Wallace, David K.

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Our understanding of plus disease as an important sign for severe retinopathy of prematurity (ROP) has gradually been refined over the past 30 years. As a result of the Early Treatment for ROP (ETROP) randomized trial, the presence of plus disease is now the primary indication for laser treatment. Since the Cryotherapy for ROP trial first introduced a standard photograph as the minimum abnormality necessary for diagnosing plus disease, an intermediate level of vascular dilatation and tortuosity (pre-plus disease) has been defined. However, the recognition of plus disease remains problematic, primarily because of its subjective nature. As our understanding of the pathologic basis for plus disease in ROP grows, objective methods of recognizing and measuring retinal vascular abnormalities are also being designed. Semiautomated methods are being developed to quantify the vascular morphologic changes seen in plus disease and show promise for augmenting clinical judgment in the recognition and timely treatment of ROP.

AB - Our understanding of plus disease as an important sign for severe retinopathy of prematurity (ROP) has gradually been refined over the past 30 years. As a result of the Early Treatment for ROP (ETROP) randomized trial, the presence of plus disease is now the primary indication for laser treatment. Since the Cryotherapy for ROP trial first introduced a standard photograph as the minimum abnormality necessary for diagnosing plus disease, an intermediate level of vascular dilatation and tortuosity (pre-plus disease) has been defined. However, the recognition of plus disease remains problematic, primarily because of its subjective nature. As our understanding of the pathologic basis for plus disease in ROP grows, objective methods of recognizing and measuring retinal vascular abnormalities are also being designed. Semiautomated methods are being developed to quantify the vascular morphologic changes seen in plus disease and show promise for augmenting clinical judgment in the recognition and timely treatment of ROP.

KW - ETROP

KW - ICROP

KW - plus disease

KW - pre-plus disease

KW - prematurity

KW - retinopathy

KW - ROPtool

KW - threshold

UR - http://www.scopus.com/inward/record.url?scp=70349778860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349778860&partnerID=8YFLogxK

U2 - 10.1016/j.survophthal.2009.02.021

DO - 10.1016/j.survophthal.2009.02.021

M3 - Review article

C2 - 19665743

AN - SCOPUS:70349778860

VL - 54

SP - 663

EP - 670

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 6

ER -